Evidence map›Paper›PMID 37496518›Full record

ArticleOphthalmology science2023

Comparative Analysis of Single-cell and Single-nucleus RNA-sequencing in a Rabbit Model of Retinal Detachment-related Proliferative Vitreoretinopathy.

Clayton P Santiago, Megan Y Gimmen, Yuchen Lu, Minda M McNally, Leighton H Duncan, Tyler J Creamer, Linda D Orzolek, Seth Blackshaw, Mandeep S Singh

Open access · goldAbstract read
In one paragraph

Article in Ophthalmology science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Advances in single-cell transcriptomics in animal research.Journal of animal science and biotechnology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Sequencing: 10X Genomics 3' HT Assay for Gene Expression.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Clayton P SantiagoSolomon H. Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland.
Megan Y GimmenSolomon H. Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland.
Yuchen LuWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Minda M McNallyWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Leighton H DuncanSolomon H. Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland.
Tyler J CreamerInstitute for Basic Biomedical Sciences, Johns Hopkins University, Baltimore, Maryland.
Linda D OrzolekInstitute for Basic Biomedical Sciences, Johns Hopkins University, Baltimore, Maryland.
Seth BlackshawSolomon H. Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland.
Mandeep S SinghWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Johns Hopkins University · US

Funding

Developing photoreceptor repair for macular degeneration therapy.R01EY033103 · NEI · JOHNS HOPKINS UNIVERSITY · PI SINGH, MANDEEP · 2021 to 2025
$2.0M
NEI NIH HHS R01 EY033103
6 · The paper itself

Abstract

Purpose: Proliferative vitreoretinopathy (PVR) is the most common cause of failure of retinal reattachment surgery, and the molecular changes leading to this aberrant wound healing process are currently unknown. Our ultimate goal is to study PVR pathogenesis by employing single-cell transcriptomics to dissect cellular heterogeneity. Design: Here we aimed to compare single-cell RNA sequencing (scRNA-seq)  and single-nucleus RNA-sequencing (snRNA-seq) of retinal PVR samples in the rabbit model. Participants: Unilateral induction of PVR lesions in rabbit eyes with contralateral eyes serving as controls. Methods: Proliferative vitreoretinopathy was induced unilaterally in Dutch Belted rabbits. At different timepoints after PVR induction, retinas were dissociated into either cells or nuclei suspension and processed for scRNA-seq or snRNA-seq. Main Outcome Measures: Single cell and nuclei transcriptomic profiles of retinas after PVR induction. Results: Single-cell RNA sequencing and snRNA-seq were conducted on retinas at 4 hours and 14 days after disease induction. Although the capture rate of unique molecular identifiers and genes were greater in scRNA-seq samples, overall gene expression profiles of individual cell types were highly correlated between scRNA-seq and snRNA-seq. A major disparity between the 2 sequencing modalities was the cell type capture rate, however, with glial cell types overrepresented in scRNA-seq, and inner retinal neurons were enriched by snRNA-seq. Furthermore, fibrotic Müller glia were overrepresented in snRNA-seq samples, whereas reactive Müller glia were overrepresented in scRNA-seq samples. Trajectory analyses were similar between the 2 methods, allowing for the combined analysis of the scRNA-seq and snRNA-seq data sets. Conclusions: These findings highlight limitations of both scRNA-seq and snRNA-seq analysis and imply that use of both techniques together can more accurately identify transcriptional networks critical for aberrant fibrogenesis in PVR than using either in isolation. Financial Disclosures: Proprietary or commercial disclosure may be found after the references.

Indexed as

FibrosisProliferative vitreoretinopathySingle cell RNA-sequencingSingle nucleus RNA-sequencing

Identifiers

PMID37496518
PMCPMC10365955
OpenAlexW4377822397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.